Skip to main content

Filler-Behandlungen mit quervernetzten Hyaluronsäure-Gelen

  • Chapter
  • First Online:
Selbstzahlerleistungen in der Dermatologie und der ästhetischen Medizin
  • 1972 Accesses

Zusammenfassung

Resorbierbare dermale Filler, wie quervernetzte Hyaluronsäure , werden in oder unter die Haut injiziert, um Linien und Falten zu korrigieren, Konturen zu schaffen, Volumen zu geben oder um Lippen und kleinere Gewebedefekte aufzufüllen. Die Produkte werden hauptsächlich im Gesichtsbereich eingesetzt, wo sie durch eine Spritze mit einer dünnen Nadel in die Dermis eingespritzt werden. Aktuelle Studien, therapeutische Strategien, praktische Anwendungshinweise zur Fillertherapie allgemein sowie detaillierte Informationen zu den Produktlinien Emervel und Restylane beinhaltet dieser ausführliche und gut bebilderte Beitrag, der wie ein Lehrbuch zur Fillertherapie aufgebaut ist.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literaturhinweise

  1. Seastone CV (1939) Virulence of group C hemolytic streptococci of animal origin. J Exp Med 70:361–378

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Richter AW, Ryde EM, Zetterström EO (1979) Non-Immunogeniticity of a Purified Sodium Hyaluronate Preparation in Man. Int Arch Allergy appl Immun 59:45–48

    Article  CAS  Google Scholar 

  3. Denlinger JL, Balazs EA (1980) Replacement of the liquid vitreus with sodium hyaluronate in monkeys. Exp Eye Res 31:81–99

    Article  CAS  PubMed  Google Scholar 

  4. Denlinger JL (1982) Metabolism of sodium hyaluronate in articular and ocular tissues. Ph. D. Thesis, Lille, France

    Google Scholar 

  5. Balazs EA, Leshchiner E (1989) Hyaluron, its Crosslinked Derivate – Hylan – and their Medical Application. In Ignaki H, Philips GO (eds) Cellulosics Utilization. Elsevier Applied Science, New York, pp 233–241

    Google Scholar 

  6. Fraser JRE, Laurent TC, Pertoft H, Baxter E (1981) Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. Biochem J 200:415–424

    CAS  PubMed Central  PubMed  Google Scholar 

  7. Larsen N.E, Pollak CT, Reiner K, Leschiner E, Balazs EA (1993) Hylan gel biomaterial: Dermal and immunologic compatibility. Journal of Biomedical Materials Research 27:1129–1134

    Article  CAS  PubMed  Google Scholar 

  8. Piacquadio D, Jarcho M, Goltz R (1977) Evaluation of hylan b gel as a soft tissue augementation implant material. J Am Acad Dermatol 36:544–549

    Article  Google Scholar 

  9. Sourdille P, Santiagi PY, Vallain F, Yamamichi M, Tahi H, Parel JM, Docournau Y (1999) Reticulated hyaluronic acid implant in nonperforming trabecular surgery. J Cataract Refract Surg 25:332–339

    Article  CAS  PubMed  Google Scholar 

  10. Piacquadio D (1995) Crosslinked Hyaluronic Acid (Hylan Gel) as Soft Tissue Augmentation Material: A preliminary Assessment. In: Elson Melvin L (ed) Evaluation and Treatment of the aging face. Springer, pp 304–308

    Google Scholar 

  11. Duranti F, Salti G, Bovani B, Calandra M, Rosati ML (1998) Injectable Hyaluronic Acid Gel for Soft Tissue Augmentation. A clinical and histological study. Dermatol Surg 24:1317–1325

    CAS  PubMed  Google Scholar 

  12. Balazs EA, Leshchiner (1986) A Cross-linked gels of Hyaluronic acid and products containing such gels. US Patent 4,582,865

    Google Scholar 

  13. Leshchiner A, Larsen NE, Balasz EA (1991) Biocompatible viscoelastics gel slurries, their prearation and use. European Patent Specification, EP 0466300 B1

    Google Scholar 

  14. Lindqvist C, Tveten S, Bondevik BE, Fagrell D (2005) A randomised, evaluator-blind multicenter comparison of the efficacy and tolerability of Perlane versus Zyplast in the correction of nasolabial fold. Plastic and Reconstructive Surgery. 115(1):282-289

    Google Scholar 

  15. Q-Med esthetics (2004) Hyaluronsäure. www.q-med.com

  16. Tveten S (2005) Faltenunterspritzung und Lippenmodellierung mit quervernetzter, stabilisierter, nicht-animalischer oder animalischer Hyaluronsäure. In: Kardorff B (Hrsg.) Selbstzahlerleistungen in der Dermatologie und der ästhetischen Medizin. Springer, Berlin Heidelberg, SS 272–278

    Chapter  Google Scholar 

  17. Huss FR et al. (2010) Use of macroporous gelatine spheres as a biodegradable scaffold for guided tissue regeneration of healthy dermis in humans: an in vivo study. J Plast Reconstr Aesthet Surg 63:848–857

    Article  PubMed  Google Scholar 

  18. Fraser JR et al. (1997) Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 242:27–33

    Article  CAS  PubMed  Google Scholar 

  19. John HE, Price D (2009) Perspectives in the selection of hyaluronic acid fillers for facial wrinkles and aging skin. Patient Preference and Adherence 3:225–230

    PubMed Central  PubMed  Google Scholar 

  20. Fisher GJ, Varani J, Voorhees JJ (2008) Looking older: fibroblast collapse and therapeutic implications. Arch Dermatol 144:666–672

    Article  PubMed Central  PubMed  Google Scholar 

  21. Röck K, Fischer JW (2011) Rolle der extrazellulären Matrix bei der extrinsischen Hautalterung. Hautarzt 62:591–597

    Article  PubMed  Google Scholar 

  22. Stocks D et al. (2011) Rheological Evaluation of the Physical Properties of Hyaluronic Acid Dermal Fillers. J Drugs Dermatol 10:974–980

    CAS  PubMed  Google Scholar 

  23. Rzany B et al. (2012) Full-face rejuvenation using a range of hyaluronic acid fillers: efficacy, safety, and patient satisfaction over 6 months. Dermatol Surg 38:1153–1611

    Article  CAS  PubMed  Google Scholar 

  24. Segura S et al. (2012) A complete range of hyaluronic acid filler with distinctive physical properties specifically designed for optimal tissue adaptations. J Drugs Dermatol 11(1 suppl):5–8

    Google Scholar 

  25. Kestemont P et al. (2012) Sustained efficacy and high patient satisfaction after cheek enhancement with a new hyaluronic acid dermal filler. J Drugs Dermatol 11(1 suppl):9–16

    Google Scholar 

  26. Cartier H et al. (2012) Perioral rejuvenation with a range of customized hyaluronic acid fillers: efficacy and safety over six months with a specific focus on the lips. J Drugs Dermatol 11(1 suppl):17–26

    Google Scholar 

  27. Rzany B et al. (2012) Correction of tear troughs and periorbital lines with a range of customized hyaluronic acid fillers. J Drugs Dermatol 11(1 suppl):27–34

    Google Scholar 

  28. Ascher B et al. (2011) Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of severe nasolabial lines - 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study. J Cosmet Dermatol 10(2):94–98

    Article  PubMed  Google Scholar 

  29. Rzany B et al. (2011) Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of moderate nasolabial folds: 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study. J Cosmet Laser Ther 13:107–112

    Article  PubMed  Google Scholar 

  30. IUPAC (1997) Compendium of Chemical Terminology, 2nd ed. (the „Gold Book“). Compiled by McNaught AD, Wilkinson A, Blackwell Scientific Publications, Oxford. XML on-line corrected version: http://goldbook.iupac.org (2006-) created by M. Nic, J. Jirat, B. Kosata; updates compiled by A. Jenkins. ISBN 0-9678550-9-8

    Google Scholar 

  31. Edsman K et al. (2012) Gel properties of hyaluronic acid dermal fillers. Dermatol surg 38: 1170-1179

    Article  CAS  PubMed  Google Scholar 

  32. Narins RS et al. (2008) Persistence and improvement of nasolabial fold correction with nonanimal-stabilized hyaluronic acid 100,000 gel particles/mL filler on two retreatment schedules: results up to 18 months on two retreatment schedules. Dermatol surg 34 suppl 1:2–8

    Google Scholar 

  33. Narins RS et al. (2011) Persistence of nasolabial fold correction with a hyaluronic acid dermal filler with retreatment: results of an 18-month extension study. Dermatol surg 37:644–650

    Article  CAS  PubMed  Google Scholar 

  34. Flynn TC, Sarazin D, Bezzola A, Terrani C, Micheels P (2011) Comparative Histology of Intradermal Implantation of Mono and Biphasic Hyaluronic Acid Filler. Dermatol Surg 37: 637–643

    Article  CAS  PubMed  Google Scholar 

  35. Hamilton RG et al. (2007) Immunogenicity Studies of Cosmetically Administered Nonanimal-Stabilized Hyaluronic Acid Particles. Dermatol Surg 33:S176–S185

    Google Scholar 

  36. Quan T et al. (2013) Enhancing Structural Support of the Dermal Microenvironment Activates Fibroblasts, Endothelial Cells, and Keratinocytes in Aged Human Skin In Vivo. J Invest Dermatol 133:658–667

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  37. Öhrlund A, et al. (2009) Size and Shape of Gel Particles in Hyaluronic Acid Dermal Fillers EADV Congress Poster

    Google Scholar 

  38. Buntrock H, Reuther T, Sattler G, Kerscher M (2012) Vergleichsuntersuchung eines monophasischen CPM- und eines biphasischen NASHA-Fillers zur Korrektur der Nasolabialfalten. Akt Dermatol 38: 423–428

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stein Tveten .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Tveten, S., Kardorff, B. (2015). Filler-Behandlungen mit quervernetzten Hyaluronsäure-Gelen. In: Kardorff, B. (eds) Selbstzahlerleistungen in der Dermatologie und der ästhetischen Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43427-7_37

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-43427-7_37

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-43426-0

  • Online ISBN: 978-3-662-43427-7

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics